You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In an editorial, Johns Hopkins University's Jennifer Axilbund argues that gene panel testing should be approached with caution.
$12 million of Q4 revenues derived from clinical testing, up 17 percent from $10.3 million a year ago, and $14.1 million from pharmaceutical customers, a 68-percent year-over-year increase.
A recent paper describes sample infrastructure for connecting tumor sequence to drugs and trials for use by labs offering oncology NGS-based panels.
National Government Services' coverage criteria are different from criteria proposed by Palmetto last year, which may impact companies like Foundation Medicine.
The companies are combining their respective products to provide a solution that covers genetic testing from sample prep to clinical reports.
The study, which will be the pediatric counterpart to the ongoing adult-only NCI-MATCH trial, will be run by the NCI in partnership with the Children's Oncology Group.
Under a national agreement, UnitedHealthcare will cover the FoundationOne genomic profiling assay in patients with metastatic stage IV non-small cell lung cancer.
The researchers looked at the first 10,030 consecutive patients referred to GeneDx for germline hereditary cancer panel testing by next-generation sequencing.
Counsyl offered its hereditary cancer panel for free to San Francisco women and found that about half who had positive results would not have been screened.
The firm has billed commercial insurers for more than 17,000 tests and reported test results for more than 15,000 Medicare patients without receiving payment.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.